Showing results (1831-1840 of 2,059) with videos related to
Sort By:
Pageof 206
Annals of the Rheumatic Diseases|September 1, 2017
Genome-wide association and functional studies identify a role for matrix Gla protein in osteoarthritis of the handWouter den Hollander, Cindy G Boer, Deborah J Hart, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 29, 2016
A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variationJessica Ezzell Hunter, Stephanie A Irving, Leslie G Biesecker, et al.Journal of Geophysical Research. Atmospheres : JGR|July 21, 2022
Increases in Future AR Count and Size: Overview of the ARTMIP Tier 2 CMIP5/6 ExperimentT A O'Brien, M F Wehner, A E Payne, et al.Journal of Internal Medicine|October 17, 2019
Weight of salivary gland ultrasonography compared to other items of the 2016 ACR/EULAR classification criteria for Primary Sjögren's syndromeS Jousse-Joulin, F Gatineau, C Baldini, et al.Cell Stem Cell|February 14, 2026
Prevention of transgene silencing during human pluripotent stem cell differentiationTakeshi Uenaka, Alan Napole, Aninda Dibya Saha, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 20, 2023
Toward robust clinical genome interpretation: Developing a consistent terminology to characterize Mendelian disease-gene relationships-allelic requirement, inheritance modes, and disease mechanismsAngharad M Roberts, Marina T DiStefano, Erin Rooney Riggs, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 28, 2022
ClinGen's Pediatric Actionability Working Group: Clinical actionability of secondary findings from genome-scale sequencing in children and adolescentsJessica Ezzell Hunter, Charisma L Jenkins, Joanna E Bulkley, et al.Annals of the Rheumatic Diseases|April 4, 2014
Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritisNils Bomer, Wouter den Hollander, Yolande F M Ramos, et al.BMC Cancer|December 3, 2022
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015-04 (PANGEA-Breast) studyL de la Cruz-Merino, M Gion, J Cruz, et al.Medrxiv : the Preprint Server for Health Sciences|April 17, 2023
Towards robust clinical genome interpretation: developing a consistent terminology to characterize disease-gene relationships - allelic requirement, inheritance modes and disease mechanismsAngharad M Roberts, Marina T DiStefano, Erin Rooney Riggs, et al.Pageof 206